Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
AstraZeneca
Boehringer Ingelheim
Express Scripts
Mallinckrodt
Cantor Fitzgerald
Queensland Health
Daiichi Sankyo
Dow

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,834,010

« Back to Dashboard

Summary for Patent: 5,834,010
Title: Triacetin as a penetration enhancer for transdermal delivery of a basic drug
Abstract:A composition and method for enhancing transdermal penetration of a basic drug are described. The composition comprises a matrix patch comprising an effective amount of a basic drug, preferably having a pK.sub.a of about 8.0 or greater, an effective amount of a penetration enhancer consisting essentially of triacetin, and a polymer layer preferably comprising a pressure-sensitive adhesive. A preferred basic drug is oxybutynin and acid addition salts thereof. The method for enhancing transdermal penetration comprises applying the matrix patch to a selected area of skin.
Inventor(s): Quan; Danyi (Salt Lake City, UT), Deshpanday; Ninad A. (Salt Lake City, UT), Venkateshwaran; Srinivasan (Salt Lake City, UT), Ebert; Charles D. (Salt Lake City, UT)
Assignee: Theratech, Inc. (Salt Lake City, UT)
Application Number:08/775,367
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 5,834,010

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,834,010

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0871420 ➤ Sign Up CA 2005 00010 Denmark ➤ Sign Up
European Patent Office 0871420 ➤ Sign Up 05C0008 France ➤ Sign Up
Denmark 0871420 ➤ Sign Up
Germany 122005000013 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Chinese Patent Office
Baxter
Accenture
Harvard Business School
McKesson
Colorcon
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.